Medicinal composition of indapamide and folic acid and application of medicinal composition
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of indapamide and its composition, which is applied in the pharmaceutical composition of indapamide and folic acid and its application field, to achieve the effect of reducing plasma Hcy level, increasing plasma folic acid level, and alleviating damage
Inactive Publication Date: 2014-12-24
SHENZHEN AUSA PHARMA +1
View PDF1 Cites 4 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Therefore, the clinical benefit / risk ratio of long-term application of indapamide in hypertensive patients needs to be further improved
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0029] Example 1: Preparation of Indapamide / Folic Acid (1.25mg / 0.4mg) Tablets (1000 Tablets)
[0030] Recipe composition:
[0031]
[0032] Preparation Process:
[0033] Mix folic acid and indapamide in equal increments, add lactose, microcrystalline cellulose, and pregelatinized starch, mix evenly, use an appropriate amount of 10% povidone ethanol solution to make a soft material, granulate, dry, and granulate , mix the granules with a water content of about 3% and an appropriate amount of magnesium stearate evenly, and make 1000 tablets according to a conventional method.
Embodiment 2
[0034] Example 2: Preparation of Indapamide / Folic Acid (2.5mg / 0.8mg) Tablets (1000 Tablets)
[0035] Recipe composition:
[0036]
[0037] The preparation process is the same as in Example 1.
[0042] According to the prescription ratio, take lactose, microcrystalline cellulose, and sodium starch glycolate and dry them at about 100°C for about 2 hours respectively. The sodium starch glycolate is passed through a 100-mesh sieve, and the lactose and microcrystalline cellulose are passed through a 80-mesh sieve; After passing through a 100-mesh sieve, it is uniformly mixed with the above-mentioned auxiliary material mixture, granulated, then mixed with an appropriate amount of glyceryl behenate, and filled with No. 3 capsules. Make 1000 capsules.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a medicinal composition prepared from indapamide, folic acid and a medicinally available carrier, and application of the composition for preparing a drug for treating hypertension with hyperhomocysteinemia and a disease of homocysteine rising. In the composition, the preferable content of indapamide is 0.625-2.5 mg, and the preferable content of folic acid is 0.4-0.8 mg. The medicinal composition disclosed by the invention has the benefits that indapamide and folic acid can be combined to reduce blood pressure, obviously lower level of homocysteine and raise the level of folic acid, so as to relieve damage of homocysteine to the blood vessel, strengthen targeted organ protection for a hypertension patient, and play a pharmacologic synergistic role. In addition, the medicinal composition can further allow the patient to take medicine conveniently and reduce the medical costs.
Description
technical field [0001] The invention relates to a pharmaceutical composition composed of indapamide and folic acid and its application in the preparation of medicines for treating hypertension accompanied by hyperhomocysteinemia or elevated homocysteine. belongs to the field of pharmacy. Background technique [0002] Hypertension is one of the most common chronic diseases, and it is also the most important risk factor for cardiovascular and cerebrovascular diseases. High, serious consumption of medical resources, a heavy burden on the family and society. The main goal of hypertension treatment is to minimize the overall risk of cardiovascular complications and death, and it is necessary to treat all reversible cardiovascular risk factors, subclinical target organ damage, and various coexisting clinical diseases [Chinese Hypertension Prevention and Treatment]. Guidelines Revision Committee. Chinese Guidelines for the Prevention and Treatment of Hypertension 2010. Chinese Jo...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more